| CMSC | 0.18% | 22.64 | $ | |
| JRI | -0.15% | 13.09 | $ | |
| BCC | -1.31% | 83.79 | $ | |
| BCE | -0.45% | 23.425 | $ | |
| BP | -0.22% | 32.18 | $ | |
| NGG | 0.18% | 70.32 | $ | |
| SCS | -0.63% | 10.265 | $ | |
| RIO | 0.46% | 59.765 | $ | |
| SCU | 0% | 12.72 | $ | |
| BTI | 1.74% | 54.1 | $ | |
| GSK | -2.22% | 38.125 | $ | |
| RBGPF | 0.52% | 74.42 | $ | |
| RYCEF | 7.55% | 14.17 | $ | |
| CMSD | 0.28% | 23.125 | $ | |
| VOD | -2.17% | 10.825 | $ | |
| AZN | -2.07% | 75.035 | $ | |
| RELX | 0.27% | 51.92 | $ |
Featured
Last news
MEMRI CHINESE MEDIA STUDIES PROJECT EXCLUSIVE: Chinese Media Praises Chinese AI Company DeepSeek: 'America's Military Dominance Has Cracked'; 'We Must... Seize Strategic High Ground, and Secure Victory in Emerging Fields'
WASHINGTON, D.C. / ACCESS Newswire / March 5, 2025 / The Middle East Media Research Institute (MEMRI) has published a new report exclusive from the MEMRI Chinese Media Studies Project (CMSP) about Chinese media praising Chinese AI company DeepSeek.
CCEP Confirms Admission to the FTSE 100 Index
UXBRIDGE, ENGLAND / ACCESS Newswire / March 5, 2025 / CCEP is one of the world's leading consumer goods companies, operating principally in the large and growing non-alcoholic ready to drink market spanning 31 countries across Western Europe and Australia, Pacific and Southeast Asia.
Ainos and ugo to Develop the World's First Robot With a Sense of Smell
A Major Breakthrough in Ainos' Mission to Digitize ScentFirst-ever Smell-Enabled Robotics Will Unlock New Revenue Streams in Smart Manufacturing, Public Safety and more
World of Coffee Geneva 2025 to Showcase 450+ Specialty Coffee Brands, Innovations, and Cutting-Edge Technology June 26-28
A Must-Attend Event Bringing Together 13,000 Coffee Professionals, Enthusiasts, and Innovators from Around the Globe
42West Shines at Toy Fair Representing Funko, the Op Games and Super7
The Top-Ranked Publicity Organization by The Observer Orchestrated an Exclusive "Game Night Reimagined" Event for The Op Games
Ensysce Biosciences to Participate in the 37th Annual ROTH Conference
SAN DIEGO, CA / ACCESS Newswire / March 5, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced its participation in the 37th Annual ROTH Conference being held Sunday, March 16th to Tuesday, March 18th at the Laguna Cliffs Marriott Resort in Dana Point, CA.
LQR House Reports 118.67% Month-Over-Month Revenue Growth in February 2025 Compared to January 2025, Achieves 63.82% Year-Over-Year Revenue Increase in February 2025 Compared to February 2024 With $0 Spent on Paid Advertising
Company's Strategic Shift to SEO-Driven Growth Continues to Deliver Outstanding Results
Medisafe Announces Collaboration with EMD Serono to Launch Global Digital HIV Resource Center
Innovative Digital Platform Empowers HIV Patients with Personalized Support to Address HIV-Associated Wasting and Fatigue
CTT Pharmaceuticals Holdings, Inc. Announces Uplisting to OTCQB Market Trading
TAMPA, FL / ACCESS Newswire / March 5, 2025 / CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) is pleased to announce the OTC Markets Group has approved the trading of its common shares on the OTCQB Market. The company's common shares will trade on the OTCQB under the symbol "CTTH" as of the opening of the market on March 10, 2025. Uplisting to the OTCQB should provide CTT with greater liquidity and a more seamless trading experience for U.S. shareholders. The OTCQB is a premier marketplace for Pharmaceutical companies in early stage that are moving towards development of new technology. Companies listed on the OTCQB are current in their reporting and undergo yearly PCAOB Audits. CTT will make a formal announcement on March 10, 2025 announcing the uplisting to the OTCQB investor community. The CEO of CTT Pharma will issue a news release to shareholders on March 12, 2025.
Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESS Newswire / March 5, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations will be presenting at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12th, 2025, at 10:30 am ET. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com. This webcast will be available for 30 days following the presentation.
Swiss prosecutors seek suspended sentences for Blatter and Platini
The Swiss public prosecutor on Tuesday requested suspended sentences of 20 months for both Sepp Blatter and Michel Platini in an appeal against their 2022 acquittal in a corruption case.
Peru's 'first poor president' on trial for rebellion
Peru's ousted ex-president Pedro Castillo went on trial accused of rebellion in Lima Tuesday for attempting to dissolve Congress and rule by decree to avoid impeachment for alleged graft.
Ramadan in 'climate of war' for east DR Congo's Muslims
Prayers at home and smaller gatherings to break the fast -- Muslims in a city recently captured by Rwanda-backed fighters in the eastern Democratic Republic of Congo face a more subdued holy month of Ramadan this year.
Pope breathing without mask after respiratory attacks: Vatican
Pope Francis was breathing without a mask on Tuesday after suffering two bouts of acute respiratory failure, the Vatican said as the leader of the world's Catholics spent his 19th day in hospital with pneumonia.
Inter and AC Milan ultras stand trial over organised crime offences
More than a dozen hardcore fans of AC Milan and Inter Milan go on trial on Tuesday facing a raft of charges relating to organised crime following a probe into the alleged illegal activities of the Serie A teams' so-called "ultras" groups.
Hundreds evacuated as torrential rains flood Indonesia capital
Hundreds evacuated from dozens of flooded neighbourhoods around Jakarta on Tuesday as torrential rains pounded the Indonesian capital and its surrounding satellite cities, causing several rivers to overflow.
Pope slept all night, resting after two breathing attacks: Vatican
Pope Francis, hospitalised with pneumonia in both lungs, slept all night and was resting on Tuesday after suffering two bouts of acute respiratory failure the day before, the Vatican said.
Thai court accepts invasive fish case against food giant
A Thai court on Tuesday accepted a class-action lawsuit filed by hundreds of fishermen seeking $73 million in damages from a agribusiness giant over invasive blackchin tilapia, a representative of the Thai lawyers' council said.
Marking Ramadan at Canada's 'Little Mosque on the Tundra'
Muslims who gathered at the Midnight Sun Mosque in the Canadian Artic to break the Ramadan fast this week enjoyed home-cooked Sudanese food in a tranquil setting with breathtaking surroundings.
Zomedica Corp. Announces Transition to OTCQB Venture Market
Zomedica's ticker symbol will change to ZOMDF
CORRECTION FROM SOURCE: New to the Street's Client Roadzen NASDAQ (RDZN) 30-Second Commercial to Air Nationwide on CNBC, Fox Business, and Bloomberg Starting This Week
This Press Release updates capitalization errors along with correcting the YouTube link.
New to the Street's Client Roadzen NASDAQ (RDZN) 30-Second Commercial to Air Nationwide on CNBC, Fox Business, and Bloomberg Starting This Week
Roadzen NASDAQ( RDZN) is a global leader in AI-driven insurance technology, leveraging advanced telematics and data science to transform roadside assistance, auto insurance, and mobility solutions. With operations across the U.S., Europe, and Asia, Roadzen is pioneering intelligent claims automation, risk assessment, and driver safety solutions that improve efficiency for insurers and enhance customer experiences.
Fortified Launches First-of-Its-Kind Collaborative Space for Healthcare Cybersecurity
Healthcare's first dedicated cybersecurity Executive Briefing Center
World's Largest Psychedelics Church Launches 'Church of Ambrosia Podcast' to Explore Psychedelics, Spiritual Growth, and Self-Discovery
OAKLAND, CA / ACCESS Newswire / March 4, 2025 / The Church of Ambrosia, the world's largest psychedelic church with over 120,000 members, proudly announces the launch of the Church of Ambrosia Podcast-a transformative new series exploring psychedelics, spirituality, and the nature of the soul.
New to The Street's Client Roadzen ($RDZN) 30-Second Commercial to Air Nationwide on CNBC, Fox Business, and Bloomberg Starting This Week
RoadZen ($RDZN) is a global leader in AI-driven insurance technology, leveraging advanced telematics and data science to transform roadside assistance, auto insurance, and mobility solutions. With operations across the U.S., Europe, and Asia, RoadZen is pioneering intelligent claims automation, risk assessment, and driver safety solutions that improve efficiency for insurers and enhance customer experiences.
42West and Shore Fire Clients Shine During Oscars Week
LOS ANGELES, CA / ACCESS Newswire / March 4, 2025 / Dolphin (NASDAQ:DLPN), a leading entertainment marketing and content production company, today celebrates its subsidiaries with clients who shined during Oscars week: 42West and Shore Fire Media. Longtime 42West client Sony Pictures Classics was recognized for their incredible work at the 97th Academy Awards with a win for I'M STILL HERE. Walter Salles' landmark film received a historic win for Brazil in Best International Feature, becoming the country's first winner in the category. The film also crossed $5,000,000 at the domestic box office this past weekend and continues to generate stellar word of mouth following its success in Brazil. I'M STILL HERE received two additional nominations for Best Picture and Best Actress. Longtime 42West client Conan O'Brien hosted the ceremony for the first time to wide acclaim.
Enchant Brands and Chef Alan Coxon Join Forces to Transform Collagen Peptides into a Culinary Delight
Innovative partnership blends culinary artistry with clean nutrition to elevate the supplement experience.
Specificity, Inc. (OTC: SPTY) Takes Another Leap Forward With AI Driven, Intent Based Data, in Its New Partnership With Blackpearl Group (BPG)
At Specificity, data integrity and audience targeting is at the core foundation of all marketing tactics. Unlike traditional marketing approaches that often contend with fraudulent or inflated audience numbers, Specificity takes a precision-driven approach to digital marketing, guaranteeing that every campaign reaches real, in-market consumers. By integrating Pearl Diver's AI-driven intent data, Specificity expands its ability to execute targeted Connected TV (CTV) campaigns with unparalleled accuracy across the nation.
PathPresenter Partners with Leading Global Cancer Center to Integrate AI Module for Oncology Research
"DeepLIIF" algorithm enhances accuracy, reproducibility, and efficiency in pathology, providing a cost-effective solution for advanced biomarker analysis
MediQuant Announces DataArk(R) Now Fully Supports U.S. Core Data for Interoperability (USCDI) Version 5
Latest integration readies healthcare organizations for evolving regulatory requirements, future interoperability initiatives
MIRA Pharmaceuticals Announces Approval and Initiation of Phase 1 Clinical Trial for Ketamir-2 in Neuropathic Pain
MIAMI, FL / ACCESS Newswire / March 4, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the approval and upcoming initiation of its Phase 1 clinical trial for Ketamir-2, the Company's novel oral ketamine analog in development for neuropathic pain, with subject recruitment scheduled to begin in Q1 2025.
Interactive Strength Inc. (Nasdaq:TRNR) Secures Exclusive Distribution and Initial Order for CLMBR in United Kingdom
The United Kingdom is the world's 3rd largest fitness marketNew UK Partner, Cranlea Human Performance, has sold CLMBRs to leading UK health clubs, including David Lloyd ClubsCranlea's 50-Year History and Leading In-Market Relationships are expected to significantly strengthen CLMBR's position in the UK